NCT04150939View on ClinicalTrials.gov

Cryoablation for the Treatment of Metastatic Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 23, 2019

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Metastatic Malignant Neoplasm
Interventions
PROCEDURE

Core Biopsy

Undergo core biospy

PROCEDURE

Cryosurgery

Undergo cryoablation

DRUG

Immunotherapeutic Agent

Receive standard of care immunotherapy

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER